The therapeutic range for INR typically varies depending on the condition being treated. For most individuals on anticoagulant therapy to prevent clots, the target INR is between 2.0 and 3.0. However, for patients with mechanical heart valves or certain other conditions, the target range might be higher, between 2.5 and 3.5. Maintaining the INR within the therapeutic range is critical to minimize the risks of both clotting and bleeding.